A new set of clinical guidelines has been released by the American Urology Association (AUA) in an effort to equip physicians with the treatment tactics necessary to remedy complications spurred by overactive bladders, urodynamics, hematuria and vasectomies.
"These guidelines are a great resource not only to AUA members, but also to physicians and patients worldwide," said J. Stuart Wolf, Jr., MD, Chair, AUA Practice Guidelines Committee, in a news release. "Some variation in treatment is appropriate for any number of reasons, but much of the variation in patient care is undesirable and reduces the quality of healthcare. The guidelines, if read carefully and applied to practice, will improve the quality of patient care."
Procured through a 9-step process reliant upon the consensus of current clinical literature, the new recommendations build upon the past while consulting the present. Overactive bladder amendments take into particular consideration the systematic review commissioned by the Agency of Healthcare Research and Quality; the same 11-member AUA and Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction committee that established the overactive bladder guidelines also put forth the counsels for adult urodynamics testing procedures, based on evidence they collected from 393 industry articles.
An AUA news release dubs the advice for asymptomatic microhematuria diagnosis, evaluation and follow-up as "useful to primary care physicians as well as urologists."
"It reflects significant changes, including a reduction in the number of urinalyses required to determine need for evaluation, the preferred radiological imaging, and follow up," the AUA added.
Meanwhile, a panel of eight -- whose expertise included preventative medicine and family medicine -- analyzed 284 articles regarding best vasectomy practices, published between 1941 and 2011. According to the AUA: "This guideline includes clear and concise statements that will help standardize and improve care for vasectomy patients by urologists and other vasectomy providers."
Treatment proposals for all four conditions are to be incorporated into the December issue of The Journal of Urology as a supplement.
"It can be difficult to sift through the vast repository of clinical information to decide what the most cost- effective care is," added journal Editor-in-Chief William D. Steers, MD, in the release. "I am proud that The Journal of Urology serves as a platform to disseminate these valuable documents to the urological community in the United States and abroad."
Gain accessibility to the supplement here.